Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charu Sharma

Showing results (161-170 of 216) with videos related to

Pageof 22
Sort By:
Heliyon|February 15, 2021
Can <i>Echinacea</i> be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019M F Nagoor Meeran, Hayate Javed, Charu Sharma, et al.
Journal of Cellular Biochemistry|November 18, 2004
MEK partner 1 (MP1): regulation of oligomerization in MAP kinase signalingCharu Sharma, Tomás Vomastek, Adel Tarcsafalvi, et al.
Tuberculosis (Edinburgh, Scotland)|January 21, 2016
Novel mutations conferring resistance to kanamycin in Mycobacterium tuberculosis clinical isolates from Northern IndiaSimerpreet Kaur, Vibhuti Rana, Pooja Singh, et al.
Current Pharmaceutical Design|May 31, 2016
Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical PromiseNeha Rani, Saurabh Bharti, Bhaskar Krishnamurthy, et al.
Trials|July 16, 2021
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trialAmbudhar Sharma, Charu Sharma, Sujeet Raina, et al.
Infection and Drug Resistance|April 15, 2022
Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in <i>M. tuberculosis</i> Clinical Isolates from Western and Northern IndiaVibhuti Rana, Nittu Singh, Chaitali Nikam, et al.
Drug Delivery|April 5, 2022
<i>In vitro</i> and <i>in vivo</i> characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approachYogeeta Agrawal, Kiran Patil, Hitendra Mahajan, et al.
Nutrients|September 9, 2022
Therapeutic Potential and Pharmaceutical Development of a Multitargeted Flavonoid PhloretinKartik T Nakhate, Hemant Badwaik, Rajesh Choudhary, et al.
Journal of Bacteriology|August 3, 2016
Interaction of Erp Protein of Mycobacterium tuberculosis with Rv2212 Enhances Intracellular Survival of Mycobacterium smegmatisArsheed Ahmad Ganaie, Garima Trivedi, Amanpreet Kaur, et al.
International Journal of Medical Sciences|September 15, 2021
Risk factor comparison in young patients presenting with acute coronary syndrome with atherosclerotic coronary artery disease vs. angiographically normal coronariesSarah Jamil, Gohar Jamil, Hanaa Mesameh, et al.
Pageof 22

Showing results (161-170 of 216) with videos related to

Sort By:
Pageof 22
Heliyon|February 15, 2021
Can <i>Echinacea</i> be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019M F Nagoor Meeran, Hayate Javed, Charu Sharma, et al.
Journal of Cellular Biochemistry|November 18, 2004
MEK partner 1 (MP1): regulation of oligomerization in MAP kinase signalingCharu Sharma, Tomás Vomastek, Adel Tarcsafalvi, et al.
Tuberculosis (Edinburgh, Scotland)|January 21, 2016
Novel mutations conferring resistance to kanamycin in Mycobacterium tuberculosis clinical isolates from Northern IndiaSimerpreet Kaur, Vibhuti Rana, Pooja Singh, et al.
Current Pharmaceutical Design|May 31, 2016
Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical PromiseNeha Rani, Saurabh Bharti, Bhaskar Krishnamurthy, et al.
Trials|July 16, 2021
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trialAmbudhar Sharma, Charu Sharma, Sujeet Raina, et al.
Infection and Drug Resistance|April 15, 2022
Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in <i>M. tuberculosis</i> Clinical Isolates from Western and Northern IndiaVibhuti Rana, Nittu Singh, Chaitali Nikam, et al.
Drug Delivery|April 5, 2022
<i>In vitro</i> and <i>in vivo</i> characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approachYogeeta Agrawal, Kiran Patil, Hitendra Mahajan, et al.
Nutrients|September 9, 2022
Therapeutic Potential and Pharmaceutical Development of a Multitargeted Flavonoid PhloretinKartik T Nakhate, Hemant Badwaik, Rajesh Choudhary, et al.
Journal of Bacteriology|August 3, 2016
Interaction of Erp Protein of Mycobacterium tuberculosis with Rv2212 Enhances Intracellular Survival of Mycobacterium smegmatisArsheed Ahmad Ganaie, Garima Trivedi, Amanpreet Kaur, et al.
International Journal of Medical Sciences|September 15, 2021
Risk factor comparison in young patients presenting with acute coronary syndrome with atherosclerotic coronary artery disease vs. angiographically normal coronariesSarah Jamil, Gohar Jamil, Hanaa Mesameh, et al.
Pageof 22